We are live on ! Find out more
Cerity Partners

Cerity Partners Portfolio holdings

AUM $70.8B
1-Year Est. Return 21.68%
This Fund
S&P 500
This Quarter Est. Return
+22.3%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
AUM
$1.81B
AUM Growth
+$222M
Cap. Flow
-$101M
Cap. Flow %
-5.61%
Top 10 Hldgs %
44.47%
Holding
499
New
59
Increased
159
Reduced
203
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 18.96%
2 Industrials 17.26%
3 Financials 8.81%
4 Healthcare 7.81%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRON
426
Cronos Group
CRON
$1.07B
$182K 0.01%
+30,300
New +$185K
KMI icon
427
Kinder Morgan
KMI
$70.6B
$180K 0.01%
11,898
-6,413
-35% -$97.5K
SABR icon
428
Sabre
SABR
$704M
$180K 0.01%
22,349
+686
+3% +$4.86K
DB icon
429
Deutsche Bank
DB
$67.9B
$169K 0.01%
17,800
-111
-0.6% -$860
ET icon
430
Energy Transfer Partners
ET
$68.5B
$152K 0.01%
21,359
+2,477
+13% +$18.4K
F icon
431
Ford
F
$58.5B
$152K 0.01%
25,035
+2,730
+12% +$15.1K
SPXS icon
432
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$348M
$148K 0.01%
+190
New +$192K
AMX icon
433
America Movil
AMX
$77.1B
$144K 0.01%
11,355
CIO
434
DELISTED
City Office REIT
CIO
$144K 0.01%
14,272
BRMK.WS
435
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
$143K 0.01%
449,148
ACRE
436
Ares Commercial Real Estate
ACRE
$257M
$137K 0.01%
+14,987
New +$117K
DBD
437
DELISTED
Diebold Nixdorf Incorporated
DBD
$123K 0.01%
+20,280
New +$100K
ORGS
438
DELISTED
Orgenesis Inc. Common Stock
ORGS
$122K 0.01%
2,000
FLR icon
439
Fluor
FLR
$7.22B
$121K 0.01%
+10,000
New +$105K
BHR
440
Braemar Hotels & Resorts
BHR
$157M
$120K 0.01%
41,912
+21,912
+110% +$63.6K
STGW icon
441
Stagwell
STGW
$1.92B
$115K 0.01%
55,500
-3,155
-5% -$4.2K
HIND
442
Vyome Holdings
HIND
$14M
0
STEW
443
SRH Total Return Fund
STEW
$1.76B
$99K 0.01%
10,500
-15,511
-60% -$147K
LAB icon
444
Standard BioTools
LAB
$303M
$93K 0.01%
23,257
+2,000
+9% +$6.97K
IVC
445
DELISTED
Invacare Corporation
IVC
$89K ﹤0.01%
13,988
LYG icon
446
Lloyds Banking Group
LYG
$89B
$59K ﹤0.01%
39,074
-725
-2% -$1.09K
RNAC icon
447
Cartesian Therapeutics
RNAC
$229M
$57K ﹤0.01%
+667
New +$60.5K
SAN icon
448
Banco Santander
SAN
$200B
$47K ﹤0.01%
+20,477
New +$44.8K
CATX icon
449
Perspective Therapeutics
CATX
$322M
$22K ﹤0.01%
+4,000
New +$25.7K
MOTS
450
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$20K ﹤0.01%
+50
New +$16.4K

Similar funds

Cerity Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Cerity Partners held 499 positions worth $1.81B, up 14% from $1.59B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cerity Partners withdrew a net $101M in Q2 2020, closing 44 positions and reducing 203 holdings. Its most notable exit was Sanofi, an estimated $6.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

Against the trend, Cerity Partners opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $3.81M.

  • Cerity Partners's largest Q2 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 28,350 shares worth $3.81M.
  • Cerity Partners added most to Vanguard S&P 500 ETF in Q2 2020, an estimated $20.8M increase.
  • Cerity Partners's biggest Q2 2020 reduction was Meta Platforms (Facebook), cutting an estimated $45.1M.
  • Cerity Partners fully exited Sanofi in Q2 2020, selling an estimated $6.3M.
  • Cerity Partners's ten largest holdings make up 44% of its $1.81B portfolio in Q2 2020.
  • Cerity Partners opened 59 new positions and closed 44 in Q2 2020.
  • Cerity Partners's portfolio value rose 14% quarter-over-quarter to $1.81B.

Based on Cerity Partners's 13F filing for Q2 2020, filed 14 Aug 2020.